Weiguo Ye

Companies

• GYRE THERAPEUTICS, INC.Chief operating officer Nov 1, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GTGYRE THERAPEUTICS, INC. GYRE700,000 shares²$4.5M at $6.40Jun 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Sold 3,000 shares at $6.35 of GYRE THERAPEUTICS, INC.²
• Jun 18, 2026Exercised options 3,000 shares at $0.75 of GYRE THERAPEUTICS, INC.²
• Jun 11, 2026Sold 2,800 shares at $6.17 of GYRE THERAPEUTICS, INC.³
• Jun 11, 2026Exercised options 2,800 shares at $0.75 of GYRE THERAPEUTICS, INC.³
• Jun 10, 2026Sold 5,000 shares at $6.24 of GYRE THERAPEUTICS, INC.²
• Jun 10, 2026Sold 6,418 shares at $6.21 of GYRE THERAPEUTICS, INC.⁴
• Jun 10, 2026Exercised options 5,000 shares at $0.75 of GYRE THERAPEUTICS, INC.²
• Jun 10, 2026Exercised options 6,418 shares at $0.75 of GYRE THERAPEUTICS, INC.⁴
• Jun 9, 2026Sold 3,000 shares at $6.15 of GYRE THERAPEUTICS, INC.²
• Jun 9, 2026Sold 14,500 shares at $6.14 of GYRE THERAPEUTICS, INC.⁴
• Jun 9, 2026Exercised options 3,000 shares at $0.75 of GYRE THERAPEUTICS, INC.²
• Jun 9, 2026Exercised options 14,500 shares at $0.75 of GYRE THERAPEUTICS, INC.⁴
• Jun 5, 2026Sold 15,401 shares at $6.40 of GYRE THERAPEUTICS, INC.⁵
• Jun 5, 2026Exercised options 15,401 shares at $0.75 of GYRE THERAPEUTICS, INC.⁵
• Jun 4, 2026Sold 19,575 shares at $6.13 of GYRE THERAPEUTICS, INC.⁵
• Jun 4, 2026Exercised options 19,575 shares at $0.75 of GYRE THERAPEUTICS, INC.⁵
• May 26, 2026Sold 4,000 shares at $6.10 of GYRE THERAPEUTICS, INC.⁶
• May 26, 2026Exercised options 4,000 shares at $0.75 of GYRE THERAPEUTICS, INC.⁶
• May 22, 2026Sold 3,500 shares at $6.08 of GYRE THERAPEUTICS, INC.⁶
• May 22, 2026Exercised options 3,500 shares at $0.75 of GYRE THERAPEUTICS, INC.⁶
• May 21, 2026Sold 12,820 shares at $6.15 of GYRE THERAPEUTICS, INC.⁷
• May 21, 2026Exercised options 12,820 shares at $0.75 of GYRE THERAPEUTICS, INC.⁷
• May 20, 2026Sold 9,400 shares at $6.15 of GYRE THERAPEUTICS, INC.⁷
• May 20, 2026Exercised options 9,400 shares at $0.75 of GYRE THERAPEUTICS, INC.⁷
• May 19, 2026Sold 9,120 shares at $6.37 of GYRE THERAPEUTICS, INC.⁸